Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 8-K call announcement, 10-Q stay in one workspace.
NTLA
$12.28
+0.16%
NTLA
· Intellia Therapeutics, Inc.
$12.28
+0.02 (+0.16%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$1.65B
Shares
140.13M
Volume · Oct 2
4.5M
Avg daily vol (3M)
3.99M
All webcasts
Earnings call · FY2026 Q1
Intellia Therapeutics, Inc. (NTLA) Q1 2026 Earnings Call
Research coverage
4 live sources
Open each available source without leaving this research workspace.
Revenue
$15.05M
-9.5% YoY
Diluted EPS
-$0.81
Net income
-$96.23M
Research materials
Open the source you need; every reader stays inside this workspace.
Company presentation
Slides
32 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed May 11, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 11, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Apr 27, 2026 · complete as-filed document